Course Finder

Research Assistant: Development of Novel Aptamers for Therapeutic and/or Diagnostic Purposes


Introduction to the topic

Dianox develops novel oligonucleotides called chemical antibodies or aptamers that can bind to proteins, small molecules, or cells with high affinity. We have developed a proprietary database and machine learning platform to create new aptamers that can bind to different targets.

You should expect to spend a lot of time reading in the beginning of the session in order to understand the fundamentals of the research.

Project details

The research project will encompass binding of aptamers to surface proteins related to cancer.

The Research Assistant will test these aptamers using fluorescence and other techniques on proteins or cancer cells lines. Over the course of the term, the Research Assistant will do weekly one-pagers and finalize the project by writing up a research paper.

Research Assistantship Hours 

You will spend 180 hours directly engaged in research, together with 20 hours in co-curricular activities, during your RAship.   

Field Studies: Culture & Language 

As a co-curricular complement to your summer research, you will meet every Wednesday, together with faculty from the DIS European Humanities program, for a 6-week introduction to culture and language in Copenhagen.  

Prerequisites

One year of biology and one year of biochemistry at university level.

Additional application required

You must submit an additional application through the Online Registration portal.

All application materials must be submitted by 23:59 Central European Time on March 15.

Complete your application through Student Registration.

Faculty

Christian Code

Faculty

Scientist with 10+ years of experience in developing new biotechnology products. Developed three marketed liposomal cancer drugs. Worked with a number of biophysical tools from fluorescence to mass spectrometry. His research has namely been with lipids (lipid protein, lipid-lipid, lipid oligonucleotide, drug) interactions. Currently, he is researching aptamers as novel therapeutics.PhD. (Biophysics, Aalto University, 2013). MSc. (Biochemistry, University of Helsinki 2010). BSc. (Molecular Biology and Biochemistry, Simon Fraser University, 2003). : Chief Technology Officer, Dianox APS, 2018-present. With DIS since 2023.

More information about your Research Assistantship

Learn more about the Labs, Research, and Practicums Summer Session.